News
Eris Lifesciences is using its growing insulin business to position itself as a serious contender in India’s fast-expanding ...
NDTV Profit on MSN41m
Gland Pharma Q1 Review: Brokerages Divided—Jefferies Upgrades Rating To Hold, Citi Maintains Sell
Jefferies upgradeed Gland Pharma to hold, as it believe earnings downcycle for the company is behind and in next 1-2 years can benefit from the generic GLP driven tailwinds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback